Effects of intrauterine exposure to synthetic glucocorticoids on fetal, newborn, and infant hypothalamic-pituitary-adrenal axis function in humans: A systematic review

Endocrine Reviews

Volumn 30, Issue 7, 2009, Pages 753-789

  Tegethoff, Marion ^a,b   Pryce, Christopher ^c   Meinlschmidt, Gunther ^a,d  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY OF TRIER   (Germany)

^c UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

^d National Centre of Competence in Research   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; DEXAMETHASONE; DRUG METABOLITE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; METYRAPONE; PREDNISOLONE;

DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG METABOLISM; DRUG PROTEIN BINDING; GESTATION PERIOD; HEART RATE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MOTHER FETUS RELATIONSHIP; NONHUMAN; ONTOGENY; PAIN; PREGNANCY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW;

FEMALE; FETUS; GLUCOCORTICOIDS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INFANT, NEWBORN; PITUITARY-ADRENAL SYSTEM; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECEPTORS, GLUCOCORTICOID;

EID: 73249150364     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/er.2008-0014     Document Type: Review

References (255)

1. Crowley P 2000 Prophylactic corticosteroids for preterm birth. Cochrane Database Syst Rev 2:CD000065
2. Lee BH, Stoll BJ, McDonald SA, Higgins RD 2006 Adverse neonatal outcomes associated with antenatal dexamethasone versus antenatal betamethasone. Pediatrics 117:1503-1510
3. Roberts D, Dalziel S 2006 Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 3:CD004454
4. Matthews SG 2000 Antenatal glucocorticoids and programming of the developing CNS. Pediatr Res 47:291-300
5. Owen D, Andrews MH, Matthews SG 2005 Maternal adversity, glucocorticoids and programming of neuroendocrine function and behaviour. Neurosci Biobehav Rev 29: 209-226
6. Seckl JR 2004 Prenatal glucocorticoids and long-term programming. Eur J Endocrinol 151 Suppl 3:U49-U62
7. Sloboda DM, Challis JR, Moss TJ, Newnham JP 2005 Synthetic glucocorticoids: antenatal administration and long-term implications. Curr Pharm Des 11:1459-1472
8. Hauser J, Dettling-Artho A, Pilloud S, Maier C, Knapman A, Feldon J, Pryce CR 2007 Effects of prenatal dexamethasone treatment on postnatal physical, endocrine, and social development in the common marmoset monkey. Endocrinology 148:1813-1822
9. Bamberger CM, Schulte HM, Chrousos GP 1996 Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocr Rev 17: 245-261
10. Grossmann C, Scholz T, Rochel M, Bumke-Vogt C, Oelkers W, Pfeiffer AF, Diederich S, BahrV2004 Transactivation via the human glucocorticoid and mineralocorticoid receptor by therapeutically used steroids in CV-1 cells: a comparison of their glucocorticoid and mineralocorticoid properties. Eur J Endocrinol 151:397-406
11. Bolt RJ, van Weissenbruch MM, Lafeber HN, Delemarrevande Waal HA 2001 Glucocorticoids and lung development in the fetus and preterm infant. Pediatr Pulmonol 32:76-91
12. Grier DG, Halliday HL 2004 Effects of glucocorticoids on fetal and neonatal lung development. Treat Respir Med 3:295-306
13. Cintra A, Bhatnagar M, Chadi G, Tinner B, Lindberg J, Gustafsson JA, Agnati LF, Fuxe K 1994 Glial and neuronal glucocorticoid receptor immunoreactive cell populations in developing, adult, and aging brain. Ann NY Acad Sci 746:42-61; discussion 61-63
14. Condon J, Gosden C, Gardener D, Nickson P, Hewison M, Howie AJ, Stewart PM 1998 Expression of type 2 11β-hydroxysteroid dehydrogenase and corticosteroid hormone receptors in early human fetal life. J Clin Endocrinol Metab 83:4490-4497
15. Cattarelli D, Chirico G, Simeoni U 2002 Renal effects of antenatally or postnatally administered steroids. Pediatr Med Chir 24:157-162
16. Jahnukainen T, Chen M, Berg U, Celsi G 2001 Antenatal glucocorticoids and renal function after birth. Semin Neonatol 6:351-355
17. O'SheaTM,DoyleLW2001 Perinatal glucocorticoid therapy and neurodevelopmental outcome: an epidemiologic perspective. Semin Neonatol 6:293-307
18. Seckl JR, Meaney MJ 2004 Glucocorticoid programming. Ann NY Acad Sci 1032:63-84
19. Phillips DI 2007 Programming of the stress response: a fundamental mechanism underlying the long-term effects of the fetal environment? J Intern Med 261:453-460
20. Charmandari E, Kino T, Souvatzoglou E, Chrousos GP 2003 Pediatric stress: hormonal mediators and human development. Horm Res 59:161-179
21. Kapoor A, Dunn E, Kostaki A, Andrews MH, Matthews SG 2006 Fetal programming of hypothalamo-pituitaryadrenal function: prenatal stress and glucocorticoids. J Physiol 572:31-44
22. Tsigos C, Chrousos GP 2002 Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res 53:865-871
23. Sapolsky RM, Romero LM, Munck AU 2000 How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev 21:55-89
24. Lindsay JR, Nieman LK 2005 The hypothalamic-pituitary-adrenal axis in pregnancy: challenges in disease detection and treatment. Endocr Rev 26:775-799
25. 1994 Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consens Statement 12:1-24
26. Liggins GC 1969 Premature delivery of foetal lambs infused with glucocorticoids. J Endocrinol 45:515-523
27. Liggins GC, Howie RN 1972 A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 50:515-525
28. Crowley PA 1995 Antenatal corticosteroid therapy: a meta-analysis of the randomized trials, 1972 to 1994.AmJ Obstet Gynecol 173:322-335
29. Meadow WL, Bell A, Sunstein CR 2003 Statistics, not memories: what was the standard of care for administering antenatal steroids to women in preterm labor between 1985 and 2000? Obstet Gynecol 102:356-362
30. National Institutes of Health Consensus Development Panel 2001 Antenatal corticosteroids revisited: repeat courses. National Institutes of Health Consensus Development Conference Statement, August 17-18, 2000. Obstet Gynecol 98:144-150
31. Diederich S, Eigendorff E, Burkhardt P, Quinkler M, Bumke-Vogt C, Rochel M, Seidelmann D, Esperling P, Oelkers W, Bähr V 2002 11β-hydroxysteroid dehydrogenase types 1 and 2: an important pharmacokinetic determinant for the activity of synthetic mineralo- and glucocorticoids. J Clin Endocrinol Metab 87:5695-5701
32. Loebstein R, Koren G 2002 Clinical relevance of therapeutic drug monitoring during pregnancy. Ther Drug Monit 24:15-22
33. Melby JC 1977 Clinical pharmacology of systemic corticosteroids. Annu Rev Pharmacol Toxicol 17:511-527
34. Petersen MC, Nation RL, McBride WG, Ashley JJ, Moore RG 1983 Pharmacokinetics of betamethasone in healthy adults after intravenous administration. Eur J Clin Pharmacol 25:643-650
35. Ballabh P, Lo ES, Kumari J, Cooper TB, Zervoudakis I, Auld PA, Krauss AN 2002 Pharmacokinetics of betamethasone in twin and singleton pregnancy. Clin Pharmacol Ther 71:39-45
36. Czock D, Keller F, Rasche FM, Häussler U 2005 Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin Pharmacokinet 44:61-98
37. Gayrard V, Alvinerie M, Toutain PL 1996 Interspecies variations of corticosteroid-binding globulin parameters. Domest Anim Endocrinol 13:35-45
38. Peets EA, Staub M, Symchowicz S 1969 Plasma binding of betamethasone-3H, dexamethasone-3H, and cortisol-14C-a comparative study. Biochem Pharmacol 18:1655-1663
39. Rocci Jr ML, D'Ambrosio R, Johnson NF, Jusko WJ 1982 Prednisolone binding to albumin and transcortin in the presence of cortisol. Biochem Pharmacol 31:289-292
40. Schwab M, Klotz U 2001 Pharmacokinetic considerations in the treatment of inflammatory bowel disease. Clin Pharmacokinet 40:723-751
41. Cummings DM, Larijani GE, Conner DP, Ferguson RK, Rocci Jr ML 1990 Characterization of dexamethasone binding in normal and uremic human serum. DICP 24: 229-231
42. Högger P 2003 [What happens in the body with glucocorticoids? Pharmacokinetics and pharmacodynamics.] Pharm Unserer Zeit 32:296-301
43. Buttgereit F, da Silva JA, Boers M, Burmester GR, Cutolo M, Jacobs J, Kirwan J, Köhler L, Van Riel P, Vischer T, BijlsmaJW2002 Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology. Ann Rheum Dis 61:718-722
44. Jobe AH, Soll RF 2004 Choice and dose of corticosteroid for antenatal treatments. Am J Obstet Gynecol 190:878-881
45. Samtani MN, Lohle M, Grant A, Nathanielsz PW, Jusko WJ 2005 Betamethasone pharmacokinetics after two prodrug formulations in sheep: implications for antenatal corticosteroid use. Drug Metab Dispos 33:1124-1130
46. Schwab M, Coksaygan T, Samtani MN, Jusko WJ, Nathanielsz PW 2006 Kinetics of betamethasone and fetal cardiovascular adverse effects in pregnant sheep after different doses. Obstet Gynecol 108:617-625
47. Pacheco LD, Ghulmiyyah LM, Snodgrass WR, Hankins GD2007 Pharmacokinetics of corticosteroids during pregnancy. Am J Perinatol 24:79-82
48. Anderson GD 2005 Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach. Clin Pharmacokinet 44:989-1008
49. Dawes M, Chowienczyk PJ 2001 Drugs in pregnancy. Pharmacokinetics in pregnancy. Best Pract Res Clin Obstet Gynaecol 15:819-826
50. Little BB 1999 Pharmacokinetics during pregnancy: evidence-based maternal dose formulation. Obstet Gynecol 93:858-868
51. Petersen MC, Collier CB, Ashley JJ, McBride WG, Nation RL 1983 Disposition of betamethasone in parturient women after intravenous administration. Eur J Clin Pharmacol 25:803-810
52. Moss TJ, Doherty DA, Nitsos I, Harding R, Newnham JP 2003 Pharmacokinetics of betamethasone after maternal or fetal intramuscular administration. Am J Obstet Gynecol 189:1751-1757
53. Olufemi OS, Whittaker PG, Halliday D, Lind T 1991 Albumin metabolism in fasted subjects during late pregnancy. Clin Sci (Lond) 81:161-168
54. Whittaker PG, Lind T 1993 The intravascular mass of albumin during human pregnancy: a serial study in normal and diabetic women. Br J Obstet Gynaecol 100:587-592
55. Benassayag C, Souski I, Mignot TM, Robert B, Hassid J, Duc-Goiran P, Mondon F, Rebourcet R, Dehennin L, Nunez EA, Ferré F 2001 Corticosteroid-binding globulin status at the fetomaternal interface during human term pregnancy. Biol Reprod 64:812-821
56. Krauer B, Dayer P, Anner R 1984 Changes in serum albumin and α 1-acid glycoprotein concentrations during pregnancy: an analysis of fetal-maternal pairs. Br J Obstet Gynaecol 91:875-881
57. Audus KL 1999 Controlling drug delivery across the placenta. Eur J Pharm Sci 8:161-165
58. KlemckeHG1995 Placental metabolism of cortisol at midand late gestation in swine. Biol Reprod 53:1293-1301
59. Osathanondh R, Tulchinsky D, Kamali H, FenclM,Taeusch Jr HW 1977 Dexamethasone levels in treated pregnant women and newborn infants. J Pediatr 90:617-620
60. Brown RW, Chapman KE, Kotelevtsev Y, Yau JL, Lindsay RS, Brett L, Leckie C, Murad P, Lyons V, Mullins JJ, Edwards CR, Seckl JR 1996 Cloning and production of antisera to human placental 11 β-hydroxysteroid dehydrogenase type 2. Biochem J 313:1007-1017
61. Benediktsson R, Calder AA, Edwards CR, Seckl JR 1997 Placental 11 β-hydroxysteroid dehydrogenase: a key regulator of fetal glucocorticoid exposure. Clin Endocrinol (Oxf) 46:161-166
62. van Runnard Heimel PJ, Franx A, Schobben AF, Huisjes AJ, Derks JB, Bruinse HW 2005 Corticosteroids, pregnancy, and HELLP syndrome: a review. Obstet Gynecol Surv 60:57-70; quiz 73-74
63. Blanford AT, Murphy BE 1977 In vitro metabolism of prednisolone, dexamethasone, betamethasone, and cortisol by the human placenta.AmJ Obstet Gynecol 127:264-267
64. van Runnard Heimel PJ, Schobben AF, Huisjes AJ, Franx A, Bruinse HW 2005 The transplacental passage of prednisolone in pregnancies complicated by early-onsetHELLP syndrome. Placenta 26:842-845
65. Ballard PL, Granberg P, Ballard RA 1975 Glucocorticoid levels in maternal and cord serum after prenatal betamethasone therapy to prevent respiratory distress syndrome. J Clin Invest 56:1548-1554
66. Murphy VE, Fittock RJ, Zarzycki PK, Delahunty MM, Smith R, CliftonVL2007 Metabolism of synthetic steroids by the human placenta. Placenta 28:39-46
67. Clifton VL, Rennie N, Murphy VE 2006 Effect of inhaled glucocorticoid treatment on placental 11β-hydroxysteroid dehydrogenase type 2 activity and neonatal birthweight in pregnancies complicated by asthma. Aust N Z J Obstet Gynaecol 46:136-140
68. Kajantie E, Dunkel L, Turpeinen U, Stenman UH, Wood PJ, Nuutila M, Andersson S 2003 Placental 11β-hydroxysteroid dehydrogenase-2 and fetal cortisol/cortisone shuttle in small preterm infants. J Clin Endocrinol Metab 88: 493-500
69. Murphy VE, Gibson PG, Giles WB, Zakar T, Smith R, Bisits AM, Kessell CG, Clifton VL 2003 Maternal asthma is associated with reduced female fetal growth.AmJ Respir Crit Care Med 168:1317-1323
70. Mark PJ, Waddell BJ 2006 P-Glycoprotein restricts access of cortisol and dexamethasone to the glucocorticoid receptor in placental BeWo cells. Endocrinology 147:5147-5152
71. Stein WD 1997 Kinetics of the multidrug transporter (P-glycoprotein) and its reversal. Physiol Rev 77:545-590
72. Uhr M, Holsboer F, Müller MB 2002 Penetration of endogenous steroid hormones corticosterone, cortisol, aldosterone and progesterone into the brain is enhanced in mice deficient for both mdr1a and mdr1b P-glycoproteins. J Neuroendocrinol 14:753-759
73. Kalabis GM, Kostaki A, Andrews MH, Petropoulos S, Gibb W, Matthews SG 2005 Multidrug resistance phosphoglycoprotein (ABCB1) in the mouse placenta: fetal protection. Biol Reprod 73:591-597
74. Sun M, Kingdom J, Baczyk D, Lye SJ, Matthews SG, Gibb W 2006 Expression of the multidrug resistance P-glycoprotein (ABCB1 glycoprotein) in the human placenta decreases with advancing gestation. Placenta 27:602-609
75. Kalabis GM, Petropoulos S, Gibb W, Matthews SG 2007 Breast cancer resistance protein (Bcrp1/Abcg2) in mouse placenta and yolk sac: ontogeny and its regulation by progesterone. Placenta 28:1073-1081
76. Kapoor A, Petropoulos S, Matthews SG 2008 Fetal programming of hypothalamic-pituitary-adrenal (HPA) axis function and behavior by synthetic glucocorticoids. Brain Res Rev 57:586-595
77. Mark PJ, Augustus S, Lewis JL, Hewitt DP, Waddell BJ 2009 Changes in the placental glucocorticoid barrier during rat pregnancy: impact on placental corticosterone levels and regulation by progesterone. Biol Reprod 80:1209-1215
78. Petropoulos S, Kalabis GM, Gibb W, Matthews SG 2007 Functional changes of mouse placental multidrug resistance phosphoglycoprotein (ABCB1) with advancing gestation and regulation by progesterone. Reprod Sci 14:321-328
79. De Kloet ER 1997 Why dexamethasone poorly penetrates in brain. Stress 2:13-20
80. De Kloet R, Wallach G, McEwen BS 1975 Differences in corticosterone and dexamethasone binding to rat brain and pituitary. Endocrinology 96:598-609
81. KarssenAM,MeijerOC,van der Sandt IC,DeBoerAG,De Lange EC, De Kloet ER 2002 The role of the efflux transporter P-glycoprotein in brain penetration of prednisolone. J Endocrinol 175:251-260
82. MeijerOC,de Lange EC, BreimerDD,de BoerAG,Workel JO, de Kloet ER 1998 Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice. Endocrinology 139:1789-1793
83. Yates CR, Chang C, Kearbey JD, Yasuda K, Schuetz EG, Miller DD, Dalton JT, Swaan PW 2003 Structural determinants of P-glycoprotein-mediated transport of glucocorticoids. Pharm Res 20:1794-1803
84. Rosati A, Maniori S, Decorti G, Candussio L, Giraldi T, Bartoli F 2003 Physiological regulation of P-glycoprotein, MRP1, MRP2 and cytochrome P450 3A2 during rat ontogeny. Dev Growth Differ 45:377-387
85. de Kloet ER, Sutanto W, van den Berg DT, Carey MP, van Haarst AD, Hornsby CD, Meijer OC, Rots NY, Oitzl MS 1993 Brain mineralocorticoid receptor diversity: functional implications. J Steroid Biochem Mol Biol 47:183-190
86. Pryce CR 2008 Postnatal ontogeny of expression of the corticosteroid receptor genes in mammalian brains: Interspecies and intra-species differences. Brain Res Rev 57: 596-605
87. Patel PD, Lopez JF, Lyons DM, Burke S, Wallace M, SchatzbergAF2000 Glucocorticoid and mineralocorticoid receptormRNAexpression in squirrelmonkeybrain. J Psychiatr Res 34:383-392
88. Seckl JR, Dickson KL, Yates C, Fink G 1991 Distribution of glucocorticoid and mineralocorticoid receptor messenger RNA expression in human postmortem hippocampus. Brain Res 561:332-337
89. Sánchez MM, Young LJ, Plotsky PM, Insel TR 2000 Distribution of corticosteroid receptors in the rhesus brain: relative absence of glucocorticoid receptors in the hippocampal formation. J Neurosci 20:4657-4668
90. Kononen J, Honkaniemi J, Gustafsson JA, Pelto-Huikko M1993 Glucocorticoid receptor colocalization with pituitary hormones in the rat pituitary gland. Mol Cell Endocrinol 93:97-103
91. Ozawa H, Ito T, Ochiai I, KawataM1999 Cellular localization and distribution of glucocorticoid receptor immunoreactivity and the expression of glucocorticoid receptor messenger RNA in rat pituitary gland. A combined double immunohistochemistry study and in situ hybridization histochemical analysis. Cell Tissue Res 295:207-214
92. De Kloet ER, Vreugdenhil E, Oitzl MS, Joëls M 1998 Brain corticosteroid receptor balance in health and disease. Endocr Rev 19:269-301
93. Herman JP, Ostrander MM, Mueller NK, Figueiredo H 2005 Limbic system mechanisms of stress regulation: hypothalamo-pituitary-adrenocortical axis. Prog Neuropsychopharmacol Biol Psychiatry 29:1201-1213
94. Speirs HJ, Seckl JR, Brown RW 2004 Ontogeny of glucocorticoid receptor and 11β-hydroxysteroid dehydrogenase type-1 gene expression identifies potential critical periods of glucocorticoid susceptibility during development. J Endocrinol 181:105-116
95. Noorlander CW, De Graan PN, Middeldorp J, Van Beers JJ, Visser GH 2006 Ontogeny of hippocampal corticosteroid receptors: effects of antenatal glucocorticoids in human and mouse. J Comp Neurol 499:924-932
96. Dobbing J, Sands J 1979 Comparative aspects of the brain growth spurt. Early Hum Dev 3:79-83
97. AndrewsMH,Matthews SG 2000 Regulation of glucocorticoid receptor mRNA and heat shock protein 70 mRNA in the developing sheep brain. Brain Res 878:174-182
98. Pryce CR, Feldon J, Fuchs E, Knuesel I, Oertle T, Sengstag C, Spengler M, Weber E, Weston A, Jongen-Rélo A 2005 Postnatal ontogeny of hippocampal expression of the mineral ocorticoid and glucocorticoid receptors in the common marmoset monkey. Eur J Neurosci 21:1521-1535
99. Bertram CE, Hanson MA 2002 Prenatal programming of postnatal endocrine responses by glucocorticoids. Reproduction 124:459-467
100. Bolt RJ, van Weissenbruch MM, Lafeber HN, Delemarrevan de Waal HA 2002 Development of the hypothalamic-pituitary-adrenal axis in the fetus and preterm infant. J Pediatr Endocrinol Metab 15:759-769
101. Brosnan PG 2001 The hypothalamic pituitary axis in the fetus and newborn. Semin Perinatol 25:371-384
102. Mesiano S, Jaffe RB 1997 Developmental and functional biology of the primate fetal adrenal cortex. Endocr Rev 18:378-403
103. Ng PC 2000 The fetal and neonatal hypothalamic-pituitary-adrenal axis. Arch Dis Child Fetal Neonatal Ed 82: F250-F254
104. Bresson JL, Clavequin MC, Fellmann D, Bugnon C 1985 Anatomical and ontogenetic studies of the human paraventriculo-infundibular corticoliberin system. Neuroscience 14: 1077-1090
105. Thliveris JA, Currie RW 1980 Observations on the hypothalamo-hypophyseal portal vasculature in the developing human fetus. Am J Anat 157:441-444
106. Baker BL, Jaffe RB 1975 The genesis of cell types in the adenohypophysis of the human fetus as observed with immunocytochemistry. Am J Anat 143:137-161
107. Asa SL, Kovacs K, Laszlo FA, Domokos I, Ezrin C 1986 Human fetal adenohypophysis. Histologic and immunocytochemical analysis. Neuroendocrinology 43:308-316
108. Sucheston ME, CannonMS1968 Development of zonular patterns in the human adrenal gland. J Morphol 126:477-491
109. Baulieu EE, Dray F 1963 Conversion of H3-dehydroisoandrosterone (3β-hydroxy-Δ5-androsten-17-one) sulfate to H3-estrogens in normal pregnant women. J Clin Endocrinol Metab 23:1298-1301
110. Macnaughton MC, Taylor T, McNally EM, Coutts JR 1977 The effect of synthetic ACTH on the metabolism of [4 -14C]-progesterone by the previable human fetus. J Steroid Biochem 8:499-504
111. Serón-Ferré M, Lawrence CC, Siiteri PK, Jaffe RB 1978 Steroid production by definitive and fetal zones of the human fetal adrenal gland. J Clin Endocrinol Metab 47:603-609
112. Giannakoulopoulos X, Sepulveda W, Kourtis P, Glover V, Fisk NM 1994 Fetal plasma cortisol and β-endorphin response to intrauterine needling. Lancet 344:77-81
113. Giannakoulopoulos X, Teixeira J, Fisk N, Glover V 1999 Human fetal and maternal noradrenaline responses to invasive procedures. Pediatr Res 45:494-499
114. Gitau R, Fisk NM, Teixeira JM, Cameron A, GloverV2001 Fetal hypothalamic-pituitary-adrenal stress responses to invasive procedures are independent of maternal responses. J Clin Endocrinol Metab 86:104-109
115. Parker Jr CR, Stankovic AM, Goland RS 1999 Corticotropin-releasing hormone stimulates steroidogenesis in cultured human adrenal cells. Mol Cell Endocrinol 155: 19-25
116. Blumenfeld Z, Jaffe RB 1986 Hypophysiotropic and neuromodulatory regulation of adrenocorticotropin in the human fetal pituitary gland. J Clin Invest 78:288-294
117. Gibbs DM, Stewart RD, Vale W, Rivier J, Yen SS 1983 Synthetic corticotropin-releasing factor stimulates secretion of immunoreactive β-endorphin/β-lipotropin and ACTH by human fetal pituitaries in vitro. Life Sci 32:547-550
118. Petraglia F, Sawchenko PE, Rivier J, ValeW1987 Evidence for local stimulation of ACTH secretion by corticotropinreleasing factor in human placenta. Nature 328:717-719
119. Goland RS, Wardlaw SL, Stark RI,BrownJr LS, FrantzAG 1986 High levels of corticotropin-releasing hormone immunoactivity in maternal and fetal plasma during pregnancy. J Clin Endocrinol Metab 63:1199-1203
120. Reichardt HM, Schütz G 1996 Feedback control of glucocorticoid production is established during fetal development. Mol Med 2:735-744
121. Pepe GJ, Albrecht ED 1995 Actions of placental and fetal adrenal steroid hormones in primate pregnancy. Endocr Rev 16:608-648
122. Pepe GJ, Waddell BJ, Stahl SJ, Albrecht ED 1988 The regulation of transplacental cortisol-cortisone metabolism by estrogen in pregnant baboons. Endocrinology 122:78-83
123. Keene MF 1927 Observations on the development of the human suprarenal gland. J Anat 61:302-324
124. Nomura S 1997 Immature adrenal steroidogenesis in preterm infants. Early Hum Dev 49:225-233
125. Banks BA, Stouffer N, Cnaan A, Ning Y, Merrill JD, Ballard RA, Ballard PL 2001 Association of plasma cortisol and chronic lung disease in preterm infants. Pediatrics 107:494-498
126. Heckmann M, Wudy SA, Haack D, Pohlandt F 1999 Reference range for serum cortisol in well preterm infants. Arch Dis Child Fetal Neonatal Ed 81:F171-F174
127. Korte C, Styne D, Merritt TA, Mayes D, Wertz A, Helbock HJ 1996 Adrenocortical function in the very low birth weight infant: improved testing sensitivity and association with neonatal outcome. J Pediatr 128:257-263
128. Hingre RV, Gross SJ, Hingre KS, MayesDM,RichmanRA 1994 Adrenal steroidogenesis in very low birth weight preterm infants. J Clin Endocrinol Metab 78:266-270
129. Lee MM, Rajagopalan L, Berg GJ, Moshang Jr T 1989 Serum adrenal steroid concentrations in premature infants. J Clin Endocrinol Metab 69:1133-1136
130. Hanna CE, Keith LD, Colasurdo MA, Buffkin DC, Laird MR, Mandel SH, Cook DM, LaFranchi SH, Reynolds JW 1993 Hypothalamic pituitary adrenal function in the extremely low birth weight infant. J Clin Endocrinol Metab 76:384-387
131. Ng PC, Wong GW, Lam CW, Lee CH, Wong MY, Fok TF, Wong W, Chan DC 1997 The pituitary-adrenal responses to exogenous human corticotropin-releasing hormone in preterm, very low birth weight infants. J Clin Endocrinol Metab 82:797-799
132. Watterberg KL, Scott SM 1995 Evidence of early adrenal insufficiency in babies who develop bronchopulmonary dysplasia. Pediatrics 95:120-125
133. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB 2000 Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 283:2008-2012
134. McAlister FA, Clark HD, van Walraven C, Straus SE, Lawson FM, Moher D, MulrowCD1999 The medical review article revisited: has the science improved? Ann Intern Med 131: 947-951
135. Szabó I, Novák P, Drozgyik I, Bódis J 1980 [The importance of the endogenous glucocorticoids in the development of foetal pulmonary maturity (author's translation)]. Z Geburtshilfe Perinatol 184:350-352
136. JaquierM,Klein A, Boltshauser E 2006 Spontaneous pregnancy outcome after prenatal diagnosis of anencephaly. BJOG 113:951-953
137. Blettner M, Sauerbrei W, Schlehofer B, Scheuchenpflug T, Friedenreich C 1999 Traditional reviews, meta-analyses and pooled analyses in epidemiology. Int J Epidemiol 28:1-9
138. Ioannidis JP, Patsopoulos NA, Rothstein HR 2008 Reasons or excuses for avoiding meta-analysis in forest plots. BMJ 336:1413-1415
139. Jüni P, Witschi A, Bloch R, EggerM1999 The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 282:1054-1060
140. Levine M, Ensom MH 2001 Post hoc power analysis: an idea whose time has passed? Pharmacotherapy 21:405-409
141. Walters SJ 2009 Consultants' forum: should post hoc sample size calculations be done? Pharm Stat 8:163-169
142. Streeten DH, Anderson Jr GH, Dalakos TG, Seeley D, Mallov JS, Eusebio R, Sunderlin FS, Badawy SZ, King RB 1984 Normal and abnormal function of the hypothalamic-pituitary-adrenocortical system in man. Endocr Rev 5:371-394
143. Ballard PL, Gluckman PD, Liggins GC, Kaplan SL, GrumbachMM1980 Steroid and growth hormone levels in premature infants after prenatal betamethasone therapy to prevent respiratory distress syndrome. Pediatr Res 14:122-127
144. Dörr HG, Versmold HT, Sippell WG, Bidlingmaier F, Knorr D 1986 Antenatal betamethasone therapy: effects on maternal, fetal, and neonatal mineralocorticoids, glucocorticoids, and progestins. J Pediatr 108:990-993
145. Gennser G, Ohrlander S, Eneroth P 1976 Cortisol in amniotic fluid and cord blood in relation to prenatal betamethasone load and delivery. Am J Obstet Gynecol 124: 43-50
146. Kairalla AB 1992 Hypothalamic-pituitary-adrenal axis function in premature neonates after extensive prenatal treatment with betamethasone: a case history. Am J Perinatol 9:428-430
147. Kajantie E, Raivio T, Jänne OA, Hovi P, Dunkel L, Andersson S 2004 Circulating glucocorticoid bioactivity in the preterm newborn after antenatal betamethasone treatment. J Clin Endocrinol Metab 89:3999-4003
148. Kauppila A, Koivisto M, Pukka M, Tuimala R 1978 Umbilical cord and neonatal cortisol levels. Effect of gestational and neonatal factors. Obstet Gynecol 52:666-672
149. Kavelaars A, van der Pompe G, Bakker JM, van Hasselt PM, Cats B, Visser GH, Heijnen CJ 1999 Altered immune function in human newborns after prenatal administration of betamethasone: enhanced natural killer cell activity and decreased T cell proliferation in cord blood. Pediatr Res 45:306-312
150. Marinoni E, Korebrits C, Di Iorio R, Cosmi EV, Challis JR 1998 Effect of betamethasone in vivo on placental corticotropin-releasing hormone in human pregnancy. Am J Obstet Gynecol 178:770-778
151. Ohrlander SA, Gennser GM, Grennert L 1975 Impact of betamethasone load given to pregnant women on endocrine balance of fetoplacental unit. Am J Obstet Gynecol 123:228-236
152. Parker Jr CR, Atkinson MW, Owen J, Andrews WW 1996 Dynamics of the fetal adrenal, cholesterol, and apolipoprotein B responses to antenatal betamethasone therapy. Am J Obstet Gynecol 174:562-565
153. Sippell WG, Bidlingmaier F, Knorr D 1980 Development of endogenous glucocorticoids, mineralocorticoids and progestins in the human fetal and perinatal period. Influence of antenatal treatment with betamethasone or phenobarbital. Eur J Clin Pharmacol 18:95-104
154. Sybulski S 1977 Effect of antepartum betamethasone treatment on cortisol levels in cord plasma, amniotic fluid, and the neonate. Am J Obstet Gynecol 127:871-874
155. Teramo K, Hallman M, Raivio KO 1980 Maternal glucocorticoid in unplanned premature labor. Controlled study on the effects of betamethasone phosphate on the phospholipids of the gastric aspirate and on the adrenal cortical function of the newborn infant. Pediatr Res 14: 326-329
156. Paddock H, Beierle EA, Chen MK, Mullett T, Wood CM, Kays DW, Langham Jr MR 2004 Administration of prenatal betamethasone suppresses the adrenal-hypophyseal axis in newborns with congenital diaphragmatic hernia. J Pediatr Surg 39:1176-1182
157. Murphy VE, Zakar T, Smith R, Giles WB, Gibson PG, Clifton VL 2002 Reduced 11β-hydroxysteroid dehydrogenase type 2 activity is associated with decreased birth weight centile in pregnancies complicated by asthma. J Clin Endocrinol Metab 87:1660-1668
158. Dörr HG, SippellWG1993 Prenatal dexamethasone treatment in pregnancies at risk for congenital adrenal hyperplasia due to 21-hydroxylase deficiency: effect on midgestational amniotic fluid steroid levels. J Clin Endocrinol Metab 76:117-120
159. Manabe M, Nishida T, Imai T, Kusaka T, Kawada K, Okada H, Okubo K, Isobe K, Itoh S 2005 Cortisol levels in umbilical vein and umbilical artery with or without antenatal corticosteroids. Pediatr Int 47:60-63
160. Nykänen P, Raivio T, Heinonen K, Jänne OA, Voutilainen R 2007 Circulating glucocorticoid bioactivity and serum cortisol concentrations in premature infants: the influence of exogenous glucocorticoids and clinical factors. Eur J Endocrinol 156:577-583
161. Gitau R, Menson E, Pickles V, Fisk NM, Glover V, MacLachlanN2001 Umbilical cortisol levels as an indicator of the fetal stress response to assisted vaginal delivery. Eur J Obstet Gynecol Reprod Biol 98:14-17
162. Mears K, McAuliffe F, Grimes H, Morrison JJ 2004 Fetal cortisol in relation to labour, intrapartum events and mode of delivery. J Obstet Gynaecol 24:129-132
163. Vogl SE, Worda C, Egarter C, Bieglmayer C, Szekeres T, Huber J, Husslein P 2006 Mode of delivery is associated with maternal and fetal endocrine stress response. BJOG 113:441-445
164. Arnold JD, Bonacruz G, Leslie GI, Veldhuis JD, Milmlow D, SilinkM1998 Antenatal glucocorticoids modulate the amplitude of pulsatile cortisol secretion in premature neonates. Pediatr Res 44:876-881
165. Bradley BS, Kumar SP, Mehta PN, Ezhuthachan SG 1994 Neonatal Cushingoid syndrome resulting from serial courses of antenatal betamethasone. Obstet Gynecol 83: 869-872
166. Karlsson R, Kallio J, Toppari J, Scheinin M, Kero P 2000 Antenatal and early postnatal dexamethasone treatment decreases cortisol secretion in preterm infants. Horm Res 53:170-176
167. Ng PC, Lam CW, Lee CH, Ma KC, Fok TF, Chan IH, Wong E 2002 Reference ranges and factors affecting the human corticotropin-releasing hormone test in preterm, very low birth weight infants. J Clin Endocrinol Metab 87:4621-4628
168. Wittekind CA, Arnold JD, Leslie GI, Luttrell B, Jones MP 1993 Longitudinal study of plasma ACTH and cortisol in very low birth weight infants in the first 8 weeks of life. Early Hum Dev 33:191-200
169. Terrone DA, Smith Jr LG, Wolf EJ, Uzbay LA, Sun S, Miller RC 1997 Neonatal effects and serum cortisol levels after multiple courses of maternal corticosteroids. Obstet Gynecol 90:819-823
170. Battin MR, Bevan C, Harding JE 2007 Repeat doses of antenatal steroids and hypothalamic-pituitary-adrenal axis (HPA) function. Am J Obstet Gynecol 197:40.e1-e6
171. Davis EP, Townsend EL, Gunnar MR, Georgieff MK, Guiang SF, Ciffuentes RF, Lussky RC 2004 Effects of prenatal betamethasone exposure on regulation of stress physiology in healthy premature infants. Psychoneuroendocrinology 29:1028-1036
172. Ng PC, Wong GW, Lam CW, Lee CH, Fok TF, Wong MY, Ma KC 1999 Effect of multiple courses of antenatal corticosteroids on pituitary-adrenal function in preterm infants. Arch Dis Child Fetal Neonatal Ed 80:F213-F216
173. Ng PC, Wong GW, Lam CW, Lee CH, Fok TF, Wong MY, Wong W, Chan DC 1997 Pituitary-adrenal suppression and recovery in preterm very low birth weight infants after dexamethasone treatment for bronchopulmonary dysplasia. J Clin Endocrinol Metab 82:2429-2432
174. Ng PC, Wong GW, Lam CW, Lee CH, Wong MY, Fok TF, Wong W, Chan DC 1997 Pituitary-adrenal response in preterm very low birth weight infants after treatment with antenatal corticosteroids. J Clin Endocrinol Metab 82:3548-3552
175. Ohrlander S, Gennser G, Nilsson KO, Eneroth P 1977 ACTH test to neonates after administration of corticosteroids during gestation. Obstet Gynecol 49:691-694
176. Sandesh Kiran PS, Dutta S, Narang A, Bhansali A, Malhi P 2007 Multiple courses of antenatal steroids. Indian J Pediatr 74:463-469
177. Shulman RJ, Heitkemper M, O'Brian Smith E, Lau C, Schanler RJ 2001 Effects of age, feeding regimen, and glucocorticoids on catecholamine and cortisol excretion in preterm infants.JPENJ Parenter Enteral Nutr 25:254-259
178. Wilson DM, Baldwin RB, Ariagno RL 1988 A randomized, placebo-controlled trial of effects of dexamethasone on hypothalamic-pituitary- adrenal axis in preterm infants. J Pediatr 113:764-768
179. MillerNM,Williamson C, FiskNM,GloverV2004 Infant cortisol response after prolonged antenatal prednisolone treatment. BJOG 111:1471-1474
180. Glover V, Miles R, Matta S, Modi N, Stevenson J 2005 Glucocorticoid exposure in preterm babies predicts saliva cortisol response to immunization at 4 months. Pediatr Res 58:1233-1237
181. NordenströmA, Wedell A, Hagenfeldt L, Marcus C, Larsson A 2001 Neonatal screening for congenital adrenal hyperplasia: 17- hydroxyprogesterone levels and CYP21 genotypes in preterm infants. Pediatrics 108:E68
182. Veldhuis JD, Iranmanesh A, Johnson ML, Lizarralde G 1990 Amplitude, but not frequency, modulation of adrenocorticotropin secretory bursts gives rise to the nyctohemeral rhythm of the corticotropic axis in man. J Clin Endocrinol Metab 71:452-463
183. Veldhuis JD, Iranmanesh A, Lizarralde G, Johnson ML 1989 Amplitude modulation of a burstlikemodeof cortisol secretion subserves the circadian glucocorticoid rhythm. Am J Physiol 257:E6-E14
184. Dalziel SR, Walker NK, Parag V, Mantell C, Rea HH, Rodgers A, Harding JE 2005 Cardiovascular risk factors after antenatal exposure to betamethasone: 30-year follow-up of a randomised controlled trial. Lancet 365:1856-1862
185. Noguchi A, Reynolds JW 1978 Serum cortisol and dehydroepiandrosterone sulfate responses to adrenocorticotropin stimulation in premature infants. Pediatr Res 12: 1057-1061
186. Terrone DA, Rinehart BK, Rhodes PG, Roberts WE, Miller RC, Martin Jr JN 1999 Multiple courses of betamethasone to enhance fetal lung maturation do not suppress neonatal adrenal response.AmJ Obstet Gynecol 180: 1349-1353
187. Ashwood PJ, Crowther CA, Willson KJ, Haslam RR, KennawayDJ, Hiller JE, Robinson JS2006Neonatal adrenal function after repeat dose prenatal corticosteroids: arandomized controlled trial. Am J Obstet Gynecol 194:861-867
188. Davis EP, Townsend EL, Gunnar MR, Guiang SF, Lussky RC, Cifuentes RF, Georgieff MK 2006 Antenatal betamethasone treatment has a persisting influence on infant HPA axis regulation. J Perinatol 26:147-153
189. Fiad TM, Kirby JM, Cunningham SK, McKenna TJ 1994 The overnight single-dose metyrapone test is a simple and reliable index of the hypothalamic-pituitary-adrenal axis. Clin Endocrinol (Oxf) 40:603-609
190. TrestmanRL,Coccaro EF, BernsteinD,Lawrence T, Gabriel SM,HorvathTB,SieverLJ1991Cortisol responses tomental arithmetic in acute and remitted depression. Biol Psychiatry 29:1051-1054
191. Kirschbaum C, Hellhammer DH 1994 Salivary cortisol in psychoneuroendocrine research: recent developments and applications. Psychoneuroendocrinology 19:313-333
192. Buske-Kirschbaum A, Fischbach S, Rauh W, Hanker J, Hellhammer D 2004 Increased responsiveness of the hypothalamus-pituitary-adrenal (HPA) axis to stress in newborns with atopic disposition. Psychoneuroendocrinology 29:705-711
193. Nelson N, Arbring K, Theodorsson E 2001 Neonatal salivary cortisol in response to heelstick: method modifications enable analysis of low concentrations and small sample volumes. Scand J Clin Lab Invest 61:287-291
194. Taylor A, Fisk NM, Glover V 2000 Mode of delivery and subsequent stress response. Lancet 355:120
195. Oken E, Kasper DL, Gleason RE, Adler GK 1998 Tetanus toxoid stimulation of the hypothalamic-pituitary-adrenal axis correlates inversely with the increase in tetanus toxoid antibody titers. J Clin Endocrinol Metab 83:1691-1696
196. Lindh V, Wiklund U, Håkansson S 1999 Heel lancing in term new-born infants: an evaluation of pain by frequency domain analysis of heart rate variability. Pain 80:143-148
197. Reis EC, Roth EK, Syphan JL, Tarbell SE, Holubkov R 2003 Effective pain reduction for multiple immunization injections in young infants. Arch Pediatr AdolescMed157: 1115-1120
198. Gatelais F, Berthelot J, Beringue F, Descamps P, Bonneau D, Limal JM, Coutant R 2004 Effect of single and multiple courses of prenatal corticosteroids on 17-hydroxyprogesterone levels: implication for neonatal screening of congenital adrenal hyperplasia. Pediatr Res 56:701-705
199. Ng PC, Lam CW, Lee CH, Wong GW, Fok TF, Wong E, Chan IH, Ma KC 2001 Changes of leptin and metabolic hormones in preterm infants: a longitudinal study in early postnatal life. Clin Endocrinol (Oxf) 54:673-680
200. Banks BA, Cnaan A, Morgan MA, Parer JT, Merrill JD, Ballard PL, BallardRA1999 Multiple courses of antenatal corticosteroids and outcome of premature neonates. North American Thyrotropin-Releasing Hormone Study Group. Am J Obstet Gynecol 181:709-717
201. Murphy KE, Hannah ME, Willan AR, Hewson SA, Ohlsson A, Kelly EN, Matthews SG, Saigal S, Asztalos E, Ross S, Delisle MF, Amankwah K, Guselle P, Gafni A, Lee SK, Armson BA 2008 Multiple courses of antenatal corticosteroids for preterm birth (MACS): a randomised controlled trial. Lancet 372:2143-2151
202. Kanitz E, Otten W, Tuchscherer M 2006 Changes in endocrine and neurochemical profiles in neonatal pigs prenatally exposed to increased maternal cortisol. J Endocrinol 191:207-220
203. de Weerth C, Zijl RH, Buitelaar JK 2003 Development of cortisol circadian rhythm in infancy. Early Hum Dev 73: 39-52
204. Easterbrook PJ, Berlin JA, Gopalan R, MatthewsDR1991 Publication bias in clinical research. Lancet 337:867-872
205. Dwan K, Altman DG, Arnaiz JA, Bloom J, Chan AW, Cronin E, Decullier E, Easterbrook PJ, Von Elm E, Gamble C, Ghersi D, Ioannidis JP, Simes J, Williamson PR 2008 Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS ONE 3:e3081
206. Lee K, Bacchetti P, Sim I 2008 Publication of clinical trials supporting successful new drug applications: a literature analysis. PLoS Med 5:e191
207. Fries E, Hesse J, Hellhammer J, Hellhammer DH 2005 A new view on hypocortisolism. Psychoneuroendocrinology 30:1010-1016
208. Heim C, Ehlert U, Hellhammer DH 2000 The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology 25: 1-35
209. Ebrecht M, Buske-Kirschbaum A, Hellhammer D, Kern S, Rohleder N, Walker B, Kirschbaum C 2000 Tissue specificity of glucocorticoid sensitivity in healthy adults. J Clin Endocrinol Metab 85:3733-3739
210. Jeffray TM, Marinoni E, Ramirez MM, Bocking AD, Challis JR 1999 Effect of prenatal betamethasone administration on maternal and fetal corticosteroid-binding globulin concentrations. Am J Obstet Gynecol 181:1546-1551
211. de Kloet ER, van der Vies J, de WiedD1974 The site of the suppressive action of dexamethasone on pituitary-adrenal activity. Endocrinology 94:61-73
212. Dean F, Matthews SG 1999 Maternal dexamethasone treatment in late gestation alters glucocorticoid and mineralocorticoid receptormRNAin the fetal guinea pig brain. Brain Res 846:253-259
213. Dean F, Yu C, Lingas RI, Matthews SG 2001 Prenatal glucocorticoid modifies hypothalamo-pituitary-adrenal regulation in prepubertal guinea pigs. Neuroendocrinology 73:194-202
214. Haley DW, Weinberg J, Grunau RE 2006 Cortisol, contingency learning, and memory in preterm and full-term infants. Psychoneuroendocrinology 31:108-117
215. Arlt W, Allolio B 2003 Adrenal insufficiency. Lancet 361: 1881-1893
216. OelkersW1996 Adrenal insufficiency.N Engl J Med 335: 1206-1212
217. Speiser PW, White PC 2003 Congenital adrenal hyperplasia. N Engl J Med 349:776-788
218. Buske-Kirschbaum A, Jobst S, Wustmans A, Kirschbaum C, Rauh W, Hellhammer D 1997 Attenuated free cortisol response to psychosocial stress in children with atopic dermatitis. Psychosom Med 59:419-426
219. Buske-Kirschbaum A, von Auer K, Krieger S, Weis S, Rauh W, Hellhammer D2003 Blunted cortisol responses to psychosocial stress in asthmatic children: a general feature of atopic disease? Psychosom Med 65:806-810
220. Buske-Kirschbaum A, Geiben A, Höllig H, Morschhäuser E, Hellhammer D 2002 Altered responsiveness of the hypothalamus-pituitary- adrenal axis and the sympathetic adrenomedullary system to stress in patients with atopic dermatitis. J Clin Endocrinol Metab 87:4245-4251
221. Carroll BJ, Feinberg M, Greden JF, Tarika J, Albala AA, Haskett RF, James NM, Kronfol Z, Lohr N, Steiner M, de Vigne JP, Young E 1981 A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility. Arch Gen Psychiatry 38:15-22
222. Chrousos GP, Gold PW 1998 A healthy body in a healthy mind-and vice versa-the damaging power of "uncontrollable" stress. J Clin Endocrinol Metab 83:1842-1845
223. Nelson JC, Davis JM 1997 DST studies in psychotic depression: a meta-analysis.AmJ Psychiatry 154:1497-1503
224. Tenhola S, Turpeinen U, Halonen P, Hämäläinen E, Voutilainen R 2005 Association of serum lipid concentrations, insulin resistance index and catch-up growth with serum cortisol/cortisone ratio by liquid chromatography tandem mass spectrometry in children born small for gestational age. Pediatr Res 58:467-471
225. Alkalay AL, Pomerance JJ, Puri AR, Lin BJ, Vinstein AL, Neufeld ND, Klein AH 1990 Hypothalamic-pituitary-adrenal axis function in very low birth weight infants treated with dexamethasone. Pediatrics 86:204-210
226. Bettendorf M, Albers N, Bauer J, Heinrich UE, Linderkamp O, Maser-Gluth C 1998 Longitudinal evaluation of salivary cortisol levels in full-term and preterm neonates. Horm Res 50:303-308
227. Cole CH, Shah B, Abbasi S, Demissie S, MacKinnon B, Colton T, Frantz 3rd ID 1999 Adrenal function in premature infants during inhaled beclomethasone therapy. J Pediatr 135:65-70
228. Ford LR, Willi SM, Hollis BW, Wright NM 1997 Suppression and recovery of the neonatal hypothalamic-pituitary-adrenal axis after prolonged dexamethasone therapy. J Pediatr 131:722-726
229. Kari MA, Raivio KO, Stenman UH, Voutilainen R 1996 Serum cortisol, dehydroepiandrosterone sulfate, and steroidbinding globulins in preterm neonates: effect of gestational age and dexamethasone therapy. Pediatr Res 40:319-324
230. Rizvi ZB, Aniol HS, Myers TF, Zeller WP, Fisher SG, Anderson CL 1992 Effects of dexamethasone on the hypothalamic-pituitary-adrenal axis in preterm infants. J Pediatr 120:961-965
231. Karemaker R, Heijnen CJ, Veen S, Baerts W, Samsom J, Visser GH, Kavelaars A, van Doornen LJ, van Bel F 2006 Differences in behavioral outcome and motor development at school age after neonatal treatment for chronic lung disease with dexamethasone versus hydrocortisone. Pediatr Res 60:745-750
232. van der Heide-Jalving M, Kamphuis PJ, van der Laan MJ, Bakker JM, Wiegant VM, Heijnen CJ, Veen S, van Bel F 2003 Short- and long-term effects of neonatal glucocorticoid therapy: is hydrocortisone an alternative to dexamethasone? Acta Paediatr 92:827-835
233. Yeh TF, Lin YJ, Huang CC, Chen YJ, Lin CH, Lin HC, Hsieh WS, Lien YJ 1998 Early dexamethasone therapy in preterm infants: a follow-up study. Pediatrics 101:E7
234. Yeh TF, Lin YJ, Lin HC, Huang CC, Hsieh WS, Lin CH, Tsai CH 2004 Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. N Engl J Med 350:1304-1313
235. Schatz M, Dombrowski MP, Wise R, Momirova V, LandonM,MabieW,NewmanRB, Hauth JC, Lindheimer M, Caritis SN, Leveno KJ, Meis P, Miodovnik M, Wapner RJ, Paul RH, Varner MW, O'Sullivan MJ, Thurnau GR, Conway DL 2004 The relationship of asthma medication use to perinatal outcomes. J Allergy Clin Immunol 113: 1040-1045
236. French NP, Hagan R, Evans SF, Godfrey M, Newnham JP 1999 Repeated antenatal corticosteroids: size at birth and subsequent development. Am J Obstet Gynecol 180:114-121
237. Modi N, Lewis H, Al-Naqeeb N, Ajayi-Obe M, Doré CJ, Rutherford M 2001 The effects of repeated antenatal glucocorticoid therapy on the developing brain. Pediatr Res 50:581-585
238. MacArthur BA, Howie RN, Dezoete JA, Elkins J 1982 School progress and cognitive development of 6-year-old children whose mothers were treated antenatally with betamethasone. Pediatrics 70:99-105
239. French NP, Hagan R, Evans SF, Mullan A, Newnham JP 2004 Repeated antenatal corticosteroids: effects on cerebral palsy and childhood behavior. Am J Obstet Gynecol 190:588-595
240. Doyle LW, Ford GW, Davis NM, Callanan C 2000 Antenatal corticosteroid therapy and blood pressure at 14 years of age in preterm children. Clin Sci (Lond) 98:137-142
241. White BP, Gunnar MR, Larson MC, Donzella B, Barr RG 2000 Behavioral and physiological responsivity, sleep, and patterns of daily cortisol production in infants with and without colic. Child Dev 71:862-877
242. Van Hoof E, De Becker P, Lapp C, Cluydts R, De Meirleir K 2007 Defining the occurrence and influence of α-Δ sleep in chronic fatigue syndrome. Am J Med Sci 333:78-84
243. Gutteling BM, de Weerth C, Buitelaar JK 2005 Prenatal stress and children's cortisol reaction to the first day of school. Psychoneuroendocrinology 30:541-549
244. DiegoMA,Field T, Hernandez-Reif M, Cullen C, Schanberg S, KuhnC2004 Prepartum, postpartum, and chronic depression effects on newborns. Psychiatry 67:63-80
245. Holsboer F, Lauer CJ, Schreiber W, Krieg JC 1995 Altered hypothalamic-pituitary-adrenocortical regulation in healthy subjects at high familial risk for affective disorders. Neuroendocrinology 62:340-347
246. O'Regan D, Kenyon CJ, Seckl JR, Holmes MC 2004 Glucocorticoid exposure in late gestation in the rat permanently programs gender-specific differences in adult cardiovascular and metabolic physiology. Am J Physiol Endocrinol Metab 287:E863-E870
247. Burlet G, Fernette B, Blanchard S, Angel E, Tankosic P, Maccari S, Burlet A 2005 Antenatal glucocorticoids blunt the functioning of the hypothalamic-pituitary-adrenal axis of neonates and disturb some behaviors in juveniles. Neuroscience 133:221-230
248. Felszeghy K, Bagdy G, Nyakas C 2000 Blunted pituitaryadrenocortical stress response in adult rats following neonatal dexamethasone treatment. J Neuroendocrinol 12:1014-1021
249. Kamphuis PJ, Bakker JM, Broekhoven MH, Kunne C, Croiset G, Lentjes EG, Tilders FJ, van Bel F, Wiegant VM 2002 Enhanced glucocorticoid feedback inhibition of hypothalamo-pituitary-adrenal responses to stress in adult rats neonatally treated with dexamethasone. Neuroendocrinology 76:158-169
250. Barbazanges A, Piazza PV, Le Moal M, Maccari S 1996 Maternal glucocorticoid secretion mediates long-term effects of prenatal stress. J Neurosci 16:3943-3949
251. Haussmann MF, Carroll JA, Weesner GD, Daniels MJ, Matteri RL, Lay Jr DC 2000 Administration of ACTH to restrained, pregnant sows alters their pigs' hypothalamicpituitary-adrenal (HPA) axis. J Anim Sci 78:2399-2411
252. Levitt NS, Lindsay RS, Holmes MC, Seckl JR 1996 Dexamethasone in the last week of pregnancy attenuates hippocampal glucocorticoid receptor gene expression and elevates blood pressure in the adult offspring in the rat. Neuroendocrinology 64:412-418
253. Muneoka K, Mikuni M, Ogawa T, Kitera K, Kamei K, Takigawa M, Takahashi K 1997 Prenatal dexamethasone exposure alters brain monoamine metabolism and adrenocortical response in rat offspring. Am J Physiol 273: R1669-R1675
254. Uno H, Eisele S, Sakai A, Shelton S, Baker E, DeJesus O, Holden J 1994 Neurotoxicity of glucocorticoids in the primate brain. Horm Behav 28:336-348
255. Welberg LA, Seckl JR 2001 Prenatal stress, glucocorticoids and the programming of the brain. J Neuroendocrinol 13: 113-128